Condition: Low Risk Prostate Cancer · Clinically Significant Prostate Cancer · Sponsor: Istanbul University - Cerrahpasa
This is a multicenter, prospective diagnostic accuracy study evaluating the Istanbul PSMA PET/CT Criteria (IPPC) for selecting patients with biopsy-confirmed low-risk prostate cancer (ISUP Grade 1) for active surveillance (AS). The study integrates delayed Ga-68 PSMA PET/CT imaging into the diagnostic pathway to refine patient stratification, minimize overtreatment and potentially reduce unnecessary biopsies and MRI, or exposing high-risk individuals to the danger of cancer progression if left untreated scans.
This description comes directly from the study's public registry record.
Levent Kabasakal, Prof. MD · 00905323667908 · lkabasakal@tsnm.org
Nalan Alan, Prof. MD. · 00905322940667 · nalanselcuk@yahoo.com
Always discuss trial participation with your own doctor first.
| Yeditepe University | Istanbul, Turkey, Turkey (Türkiye) | Recruiting |
| Bilkent Şehir Hastanesi | Ankara, Turkey (Türkiye) | Recruiting |
| Gazi Yaşargil Egitim ve Arastirma Hastanesi | Diyarbakır, Turkey (Türkiye) | Recruiting |
| Gaziantep Üniversitesi Şahinbey Araştırma ve Uygulama hastanesi | Gaziantep, Turkey (Türkiye) | Recruiting |
| Acibadem University Altunizade Hospital | Istanbul, Turkey (Türkiye) | Recruiting |
| Acibadem University Maslak Hospital | Istanbul, Turkey (Türkiye) | Recruiting |
| Haseki Eğitim ve Araştırma Hastanesi | Istanbul, Turkey (Türkiye) | Recruiting |
| Istanbul University-Cerrahpaşa | Istanbul, Turkey (Türkiye) | Recruiting |
| SBÜ Başakşehir Çam Sakura Şehir hastanesi | Istanbul, Turkey (Türkiye) | Recruiting |
| Sisli Hamidiye Etfal Eğitim ve Arastırma Hastanesi | Istanbul, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07168616